Trump vows to slash drug prices and boost U.S. manufacturing, but tariffs and market realities may drive costs higher instead ...

The Trump administration has issued numerous pharma-focused executive orders, including “Lowering Drug Prices by Once Again Putting Americans ...

From rethinking launch price logic to implementing rebate-aware modeling and patient-first access programs, this installment ...

Gain insights from Humacyte's Q2 2025 earnings call, highlighting Symvess' commercial expansion, strategic pricing, pipeline progress, and ...